Latest revenue
$257.7M
as of 2026-04-03
Latest net income
—
as of 2026-04-03
Net margin
—
as of 2026-04-03
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $5.69B
- Enterprise value
- $5.69B
- P/E (trailing)
- 105.7×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $165.56
- 52-wk low
- $98.27
- Beta
- —
- Shares out
- 35.6M
5-year trend
What this company does
Item 1. Business Overview Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables us to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications.…
AI summary unavailable — showing raw filing excerpt
Generated from NOVT's filing dated 2026-02-23
Key risks
Item 1A. Risk Factors The following risk factors could have a material adverse effect on our business, financial position, results of operations and cash flows and could cause the market value of our common shares to fluctuate or decline. These risk factors may not include all of the important factors that could affect our business or that could cause our future financial results to differ materially from historical or expected results or cause the market price of our common shares to fluctuate or decline. Risks Relating to Our Business Our results of operations could be adversely affected by economic and political conditions and the effects of these conditions on our customers’ businesses,…
AI summary unavailable — showing raw filing excerpt
Generated from NOVT's filing dated 2026-02-23
Profitability
Gross margin
44.4%
0.0%Operating margin
9.6%
17.7%Net margin
5.5%
18.7%Return on equity
4.1%
52.3%Return on assets
3.0%
35.5%Leverage
Debt / equity
0.37×
56.5%Long-term debt / equity
0.16×
70.7%Debt / assets
27.3%
41.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q2 2026 2026-04-03 | $257.7M | +10.4% | — | — | — |
Q4 2025 2025-12-31 | $258.3M | +8.5% | — | — | — |
Q3 2025 2025-09-26 | $247.8M | +1.4% | — | — | — |
Q2 2025 2025-06-27 | $241.0M | +2.2% | — | — | — |
Q1 2025 2025-03-28 | $233.4M | +1.1% | — | — | — |
Q4 2024 2024-12-31 | $238.1M | — | — | — | — |
Q3 2024 2024-09-27 | $244.4M | +10.3% | — | — | — |
Q2 2024 2024-06-28 | $235.9M | +2.8% | — | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Miscellaneous Electrical Machinery, Equipment & Supplies · SIC 3690
Your notes
Keep private notes on NOVT — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$9.3M
Net activity
−$9.3M
Distinct insiders
3
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns NOVT
Institutional value
$2.70B
Total shares held
24.2M
Distinct holders
208
-117 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.7M | $549.8M | +74.2K (+1.6%) | Added |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5M | $292.5M | — | New |
| 3 | Allspring Global Investments Holdings, LLC | 1.8M | $210.3M | +377.2K (+27.0%) | Added |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.6M | $190.5M | — | New |
| 5 | Conestoga Capital Advisors, LLC | 1.4M | $171.2M | -8.4K (-0.6%) | Trimmed |
| 6 | WASATCH ADVISORS LP | 996.6K | $117.7M | +351.9K (+54.6%) | Added |
| 7 | GENEVA CAPITAL MANAGEMENT LLC | 931.3K | $110.0M | +28.2K (+3.1%) | Added |
| 8 | CONGRESS ASSET MANAGEMENT CO | 909.7K | $107.4M | +297.7K (+48.7%) | Added |
| 9 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 783.1K | $92.5M | -125.8K (-13.8%) | Trimmed |
| 10 | DIMENSIONAL FUND ADVISORS LP | 631.8K | $74.6M | +33.9K (+5.7%) | Added |
| 11 | JPMORGAN CHASE & CO | 643.2K | $72.7M | -138.4K (-17.7%) | Trimmed |
| 12 | SEI INVESTMENTS CO | 484.3K | $57.2M | +156.3K (+47.6%) | Added |
| 13 | Mawer Investment Management Ltd. | 482.2K | $57.0M | +25.0K (+5.5%) | Added |
| 14 | BARROW HANLEY MEWHINNEY & STRAUSS LLC | 411.5K | $48.6M | +64.9K (+18.7%) | Added |
| 15 | Champlain Investment Partners, LLC | 392.1K | $46.3M | -88.9K (-18.5%) | Trimmed |
| 16 | Telemark Asset Management, LLC | 375.0K | $44.3M | +0 (+0.0%) | No change |
| 17 | Bank of New York Mellon Corp | 302.6K | $35.7M | +75.7K (+33.4%) | Added |
| 18 | VANGUARD FIDUCIARY TRUST CO | 249.0K | $29.4M | — | New |
| 19 | EXCHANGE TRADED CONCEPTS, LLC | 215.6K | $25.5M | +15.6K (+7.8%) | Added |
| 20 | Legal & General Group Plc | 209.2K | $24.7M | +2.2K (+1.0%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once NOVT's latest filing finishes processing.